首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C
【2h】

Quantitative Structure-Activity Relationship Studies on Indenoisoquinoline Topoisomerase I Inhibitors as Anticancer Agents in Human Renal Cell Carcinoma Cell Line SN12C

机译:茚并异喹啉拓扑异构酶I抑制剂作为人类肾细胞癌细胞株SN12C抗癌剂的定量构效关系研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Topoisomerase I is important for DNA replication and cell division, making it an attractive drug target for anticancer therapy. A series of indenoisoquinolines displaying potent Top1 inhibitory activity in human renal cell carcinoma cell line SN12C were selected to establish 3D-QSAR models using CoMFA and CoMSIA methods. Internal and external cross-validation techniques were investigated, as well as some measures taken, including region focusing, bootstrapping and the “leave-group-out” cross-validation method. The satisfactory CoMFA model predicted a q2 value of 0.659 and an r2 value of 0.949, indicating that electrostatic and steric properties play a significant role in potency. The best CoMSIA model, based on a combination of steric, electrostatic and H-bond acceptor descriptors, predicted a q2 value of 0.523 and an r2 value of 0.902. The models were graphically interpreted by contour plots which provided insight into the structural requirements for increasing the activity of a compound, providing a solid basis for future rational design of more active anticancer agents.
机译:拓扑异构酶I对于DNA复制和细胞分裂非常重要,使其成为抗癌治疗的诱人药物靶标。选择一系列在人肾癌细胞系SN12C中显示强效Top1抑制活性的茚并异喹啉,以使用CoMFA和CoMSIA方法建立3D-QSAR模型。研究了内部和外部交叉验证技术以及采取的一些措施,包括区域聚焦,自举和“ leave-group-out”交叉验证方法。令人满意的CoMFA模型预测q 2 值为0.659,r 2 值为0.949,表明静电和位阻性质在效价中起重要作用。最好的CoMSIA模型基于空间,静电和H键受体描述子的组合,预测q 2 值为0.523,r 2 值为0.902。通过等高线图对模型进行图形解释,等高线图提供了对提高化合物活性的结构要求的见解,为将来更合理地设计活性更高的抗癌剂提供了坚实的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号